Karissa Waddick
EditorKarissa Waddick is an editor for PharmaVoice. She most recently covered the ins and outs of workplace safety and health policy for Inside Washington Publishers, writing about federal and local COVID-19 vaccine regulations. Prior to that role, she helped build a database of need-to-know policy and business influencer profiles at National Journal. Though a Boston-area native, Karissa moved to the Washington, D.C., area to attend American University and has stayed ever since. She is an avid Red Sox fan, amateur photographer and crafting enthusiast.
59 articles by Karissa Waddick
-
With Twitter in flux, pharma is turning to alternative social spaces
Jan. 26, 2023 -
Already on a roll in oncology, Astellas hunts for big wins in other areas
Jan. 23, 2023 -
Pro sports’ COVID protocols led to real-world data impacts for pharma
Jan. 16, 2023 -
C-suite changes at Biogen, Bluebird, Novavax give insight into 2023 business plans
Jan. 10, 2023 -
From chemistry to canvas: What the pharma world can learn from art
Dec. 22, 2022 -
To drive trial diversity, one company is bringing them to the patient
Dec. 21, 2022 -
Can pharma quit Twitter? Social strategy evolves as Musk changes the platform
Dec. 16, 2022 -
With FDA filing on the horizon, Karuna appoints new CEO
Dec. 9, 2022 -
10 noteworthy pharma leadership shake-ups this year
Dec. 7, 2022 -
An FDA proposal could make OTC switches easier. Here’s what the industry has to say
Dec. 5, 2022 -
One biotech’s approach to science-driven innovation
Nov. 29, 2022 -
Executive changes at Teva, Eversana could spell commercial growth in the new year
Nov. 23, 2022 -
The next era of Greater Boston’s biotech boom
Nov. 22, 2022 -
4 pioneering social media campaigns in pharma this year
Nov. 17, 2022 -
This plant-based gel stops bleeding in seconds — and might have potential in drug delivery
Nov. 9, 2022 -
What pharma could gain — or lose — from the midterms
Nov. 7, 2022 -
How Europe’s energy crisis is impacting pharma
Nov. 2, 2022 -
Vaccine chief’s exit spurs new slate of GSK executive changes
Oct. 31, 2022 -
The first company to use Nobel-winning click chemistry in humans is on a mission to transform oncology
Oct. 27, 2022 -
Nobel Prize winner Carolyn Bertozzi on revealing the power of chemistry in drug development
Oct. 26, 2022 -
Think your company could be on HHS’ drug price negotiation list? Here’s how to navigate next steps
Oct. 18, 2022 -
BIO’s interim CEO and Alvotech’s new chief quality officer could spell big changes for biotech
Oct. 14, 2022 -
Robotic pills could open a world of possibilities for the biologics market
Oct. 13, 2022 -
Citius Pharmaceuticals sees golden opportunities in late-stage specialty assets
Oct. 11, 2022 -
Her antibiotic company failed. Now she’s helping others avoid the same fate.
Oct. 6, 2022